Insight Molecular Diagnostics Inc. — Director's Dealing 2020

Dec 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2020-12-11

Reporting Person: KINGSLEY ALFRED D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-11	Common Stock	A	5909	—	Acquired	302811	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	75345	Indirect
Common Stock	18767	Indirect

Footnotes

F1: The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share.

F2: The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.

F3: The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.